|
Lymphoma
|
C15.604.515.569 |
|
|
Nitrogen
|
D01.362.625 |
|
|
Attention Deficit Disorder with Hyperactivity
|
F03.625.094.150 |
|
|
Serum Response Factor
|
D12.776.930.397.875 |
|
|
Apolipoprotein L1
|
D12.776.521.120.750.500 |
|
|
Apolipoproteins L
|
D12.776.521.120.750 |
|
|
Isoxsuprine
|
D02.033.100.624.427 |
|
|
Glomerulonephritis, Membranoproliferative
|
C20.425 |
|
|
Age of Onset
|
N06.850.490.250.100 |
|
|
Esophageal Atresia
|
C06.198.330 |
|
|
Leukoencephalopathy, Progressive Multifocal
|
C10.314.450 |
|
|
Phenylisopropyladenosine
|
D03.633.100.759.590.138.630 |
|
|
Perchlorates
|
D01.029.260.650 |
|
|
Cardiac Output, High
|
C23.888.176 |
|
|
Philosophy
|
K01.752 |
|
|
Nitric Oxide
|
D01.625.550.500 |
|
|
Nitrogen Oxides
|
D01.625.550 |
|
|
Cytokine Receptor Common beta Subunit
|
D12.776.543.750.705.852.150.310.500 |
|
|
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor
|
D12.776.543.750.705.852.150.310 |
|
|
Hypermastigia
|
B01.630.399 |
|
